 Kevin Rothchild
Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 8 | 2023 | 293 | 0.870 |
Why?
| | Gastric Bypass | 5 | 2023 | 126 | 0.680 |
Why?
| | Bariatric Surgery | 3 | 2022 | 253 | 0.290 |
Why?
| | Weight Loss | 5 | 2023 | 859 | 0.220 |
Why?
| | Paracrine Communication | 1 | 2025 | 67 | 0.220 |
Why?
| | Pancreas | 1 | 2025 | 341 | 0.180 |
Why?
| | Laparoscopy | 3 | 2015 | 481 | 0.170 |
Why?
| | Insurance | 1 | 2021 | 14 | 0.170 |
Why?
| | Adipose Tissue | 1 | 2025 | 645 | 0.160 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1454 | 0.140 |
Why?
| | Gastrectomy | 2 | 2022 | 166 | 0.130 |
Why?
| | Neoplasms, Experimental | 3 | 2004 | 167 | 0.130 |
Why?
| | Cefoxitin | 1 | 2016 | 8 | 0.120 |
Why?
| | Gastric Acid | 1 | 2014 | 12 | 0.110 |
Why?
| | Insulin | 1 | 2025 | 2516 | 0.100 |
Why?
| | Proton Pump Inhibitors | 1 | 2014 | 109 | 0.100 |
Why?
| | Body Mass Index | 3 | 2022 | 2447 | 0.100 |
Why?
| | Mental Disorders | 1 | 2022 | 1171 | 0.100 |
Why?
| | Surgical Wound Infection | 1 | 2016 | 329 | 0.090 |
Why?
| | Insurance Coverage | 1 | 2015 | 244 | 0.090 |
Why?
| | Postoperative Care | 1 | 2014 | 286 | 0.090 |
Why?
| | Gastroesophageal Reflux | 1 | 2014 | 237 | 0.090 |
Why?
| | Medicaid | 1 | 2015 | 467 | 0.080 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2001 | 162 | 0.080 |
Why?
| | Retrospective Studies | 7 | 2023 | 17330 | 0.070 |
Why?
| | Patient Readmission | 1 | 2015 | 773 | 0.070 |
Why?
| | Length of Stay | 1 | 2015 | 1350 | 0.070 |
Why?
| | Subcutaneous Fat | 1 | 2025 | 79 | 0.050 |
Why?
| | T-Lymphocyte Subsets | 2 | 2004 | 420 | 0.050 |
Why?
| | Complementarity Determining Regions | 1 | 2004 | 54 | 0.050 |
Why?
| | Antibodies, Monoclonal | 2 | 2001 | 1505 | 0.050 |
Why?
| | Obesity | 1 | 2016 | 3118 | 0.050 |
Why?
| | Quality of Life | 1 | 2015 | 3211 | 0.050 |
Why?
| | Suture Techniques | 1 | 2023 | 137 | 0.040 |
Why?
| | Vasodilation | 1 | 2025 | 521 | 0.040 |
Why?
| | Demography | 1 | 2022 | 282 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2023 | 11794 | 0.040 |
Why?
| | Receptors, Nerve Growth Factor | 1 | 2001 | 18 | 0.040 |
Why?
| | Adult | 6 | 2025 | 40881 | 0.040 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2000 | 28 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2004 | 343 | 0.040 |
Why?
| | Endoscopy | 1 | 2023 | 317 | 0.040 |
Why?
| | Reoperation | 1 | 2023 | 637 | 0.040 |
Why?
| | Emergency Service, Hospital | 2 | 2022 | 2383 | 0.040 |
Why?
| | Weight Gain | 1 | 2023 | 561 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2025 | 847 | 0.040 |
Why?
| | Humans | 9 | 2025 | 145783 | 0.030 |
Why?
| | Female | 9 | 2025 | 79045 | 0.030 |
Why?
| | Monte Carlo Method | 1 | 2016 | 148 | 0.030 |
Why?
| | Middle Aged | 4 | 2025 | 36309 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 335 | 0.030 |
Why?
| | T-Lymphocytes | 2 | 2001 | 1998 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 134 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2015 | 5428 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 365 | 0.030 |
Why?
| | Gastric Acidity Determination | 1 | 2014 | 6 | 0.030 |
Why?
| | Hospitals, University | 1 | 2015 | 176 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2934 | 0.030 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 195 | 0.020 |
Why?
| | Time Factors | 2 | 2015 | 7134 | 0.020 |
Why?
| | Male | 5 | 2025 | 73011 | 0.020 |
Why?
| | Body Weight | 1 | 2016 | 972 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2028 | 0.020 |
Why?
| | Lymph Nodes | 2 | 2004 | 509 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1491 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2021 | 2977 | 0.020 |
Why?
| | Patient Discharge | 1 | 2015 | 995 | 0.020 |
Why?
| | United States | 2 | 2015 | 16126 | 0.020 |
Why?
| | L-Selectin | 1 | 2004 | 27 | 0.010 |
Why?
| | Cohort Studies | 1 | 2015 | 6033 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 263 | 0.010 |
Why?
| | Mice, Inbred BALB C | 1 | 2004 | 1261 | 0.010 |
Why?
| | Antibody-Dependent Cell Cytotoxicity | 1 | 2001 | 21 | 0.010 |
Why?
| | Brain Neoplasms | 2 | 2001 | 1331 | 0.010 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2001 | 23 | 0.010 |
Why?
| | Sarcoma, Experimental | 1 | 2000 | 6 | 0.010 |
Why?
| | Receptors, OX40 | 1 | 2000 | 16 | 0.010 |
Why?
| | Mice | 3 | 2004 | 18356 | 0.010 |
Why?
| | Mice, SCID | 1 | 2001 | 369 | 0.010 |
Why?
| | Melanoma, Experimental | 1 | 2000 | 109 | 0.010 |
Why?
| | Mice, Inbred C57BL | 2 | 2001 | 5993 | 0.010 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2000 | 154 | 0.010 |
Why?
| | Epitopes | 1 | 2001 | 473 | 0.010 |
Why?
| | Young Adult | 1 | 2015 | 14254 | 0.010 |
Why?
| | Antigens, CD | 1 | 2001 | 558 | 0.010 |
Why?
| | Glioma | 1 | 2000 | 429 | 0.010 |
Why?
| | Animals | 3 | 2004 | 38102 | 0.010 |
Why?
| | Phenotype | 1 | 2001 | 3170 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2001 | 2668 | 0.000 |
Why?
|
|
Rothchild's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|